Table 1 Primers used for PCR.

From: A double-Flp-in method for stable overexpression of two genes

Primers used for generation of pcDNA5/FRTpuro vector

Fragment

Primer

Sequene (5′–3′)

Amplicon size (bp)

pcDNA5 backbone

PuroR_p5_fwd

cacgaccccatgGGCTGGATGATCCTCCAGCG

3,834

SV40/FRT_p5_rev

gacacgtacgtacgtGGCGAACGTGGCGAGAAAGG

Puromycin resistance

SV40/FRT_PuroR_fwd

ttccttggccACCGAGTACAAGCCCACGG

669

p5_PuroR_rev

tcatccagccCATGGGGTCGTGCGCTCC

SV40 promotor-FRT region

p5_SV40/FRT_fwd

gccacgtacgtacgtGTCAGTTAGGGTGTGGAAAG

395

PuroR_SV40/FRT_rev

tcggtggccaagGAAGTTCCTATACTTTCTAGAG

Primers used for site-directed mutagenesis

Vector

Primer

Sequence (5′–3′)

Amplicon size (bp)

pcDNA5/FRThygro

SDM_hygro_fwd

GTATAGGAACTTCCTTGGC-AAAAAGCCTGAACTCACC

N/A

SDM_hygro_rev

GGTGAGTTCAGGCTTTTT-GCCAAGGAAGTTCCTATAC

pcDNA5/FRTpuro

SDM_puro_fwd

CATGGCAGAAGTTCCTATTCCGAAGTTCC

N/A

SDM_puro_rev

AATAGGAACTTCTGCCATGGTAGCCTCC

Primers used for cloning of CYP2C19

Reaction

Primer

Sequence (5′–3′)

Amplicon size (bp)

Reverse transcription

CYP2C19_GSP_rev

GAGGAAAGAGAGCTGCAGGG

N/A

Introduction of restriction sites

CYP2C19_HindIII_fwd

AAGAGGAGaagcttACCATGGATCCTTTTGTGGTCCTTG

1516

CYP2C19_EcoRV_rev

CATCTGTgatatcTCAGACAGGAATGAAGCACAGC

Primers used for Validation PCRs

Reaction

Primer

Sequence (5′–3′)

Amplicon size (bp)

Integration PCR 1

PSV40

AGCTGTGGAATGTGTGTCAGTTAGG

559

Ppuro_r

CGACGCGCGTGAGGAAGAGTTCTTG

Integration PCR 2

Puni_f

CGTTCGCCACGTACGTACGTGTCAG

489

Phyr_r

CTTCGCCCTCCGAGAGCTGCATCAG

Multiple Integration PCR A

Puni_f

CGTTCGCCACGTACGTACGTGTCAG

564

Ppuro_r

CGACGCGCGTGAGGAAGAGTTCTTG

Multiple Integration PCR B

PFRT_f

AATCGGGGGCTCCCTTTAGGGTTCC

313

Ppuro_r

CGACGCGCGTGAGGAAGAGTTCTTG

Multiple Integration PCR C

PFRT_f

AATCGGGGGCTCCCTTTAGGGTTCC

238

Phyr_r

CTTCGCCCTCCGAGAGCTGCATCAG

Primers used for quantitative RT-PCR

Gene

Primer

Sequence (5′-3′)

Amplicon size (bp)

CYP2C19

PCYP2C19_f

CCTGATCAAAATGGAGAAGGAAAAG

99

PCYP2C19_r

TCTGTCCCAGCTCCAAGTAAG

HPRT1

PHPRT1_f

TGACACTGGCAAAACAATGCA

94

PHPRT1_r

GGTCCTTTTCACCAGCAAGCT

OCT1

POCT1_f

TGTCACCGAAAAGCTGAGCC

96

POCT1_r

TCCGTGAACCACAGGTACATC

  1. The 5′-hybrid part of primers used for generation of overlapping amplicons for creation of the pcDNA5/FRTpuro vector is shown by nucleotides in small capital letters. The unique sequence introduced into the generated vector is underscored. The newly introduced base into the pcDNA5/FRTpuro vector for frame shift generation is marked in bold, the nucleotide substitution for the correction of the FRT site is highlighted by an italic, bold letter. The position of the single nucleotide deletion introduced into the pcDNA5/FRThygro vector is shown by a hyphen. Endonuclease restriction sites are indicated by lower case letters.